EUVIMEDEUVIMED entdecken
Crossref

Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method

Zhongwen Sun iD, Chao Qiu, Yiqiang An, Zhengyuan Yan, Caifu Li

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Zhongwen Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Lishui University, Lishui, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Saponins, Oleanolic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Joint Fund of Zhejiang Provincial Natural Science Foundation of China, Lishui University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Saikosaponin A (SSa) is an oleanane type triterpenoid saponin isolated from Radix Bupleuri ( Bupleurum chinense DC). While SSa has demonstrated significant pharmacological activities including anti‐inflammatory, antioxidant, and antidepressant effects, its pharmacokinetic profile remains poorly characterized. This study developed and validated a sensitive LC–MS/MS method for quantifying SSa in rat plasma. After acetonitrile‐mediated protein precipitation, SSa and the internal standard (IS) were separated on a Waters Acquity BEH C18 column using MS detection operated in negative multiple reaction monitoring (MRM) mode. The assay was linear over the concentration range of 2–1000 ng/mL with satisfactory validation parameters of intra‐and inter‐day precision (3.50%–10.01%) and accuracy (−5.93% to −2.68%), extraction recovery (73.75%–82.50%), stability, and matrix effect (88.49%–103.64%). Application in pharmacokinetic studies revealed distinct administration‐related characteristics. Intravenous administration (5 mg/kg) resulted in high clearance with an elimination half‐life ( t 1/2 ) of 2.29 h and was accompanied by hemolysis. Oral administration at doses of 50, 100, and 200 mg/kg showed dose‐dependent systemic exposure with consistently low bioavailability (0.04%). The limited absorption is likely attributable to poor gastrointestinal permeability and extensive metabolism mediated by intestinal microbiota and hepatic first‐pass effects, as indicated by the extremely low system exposure. These findings provide useful information for optimizing SSa therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySaponinsOleanolic AcidAnimalsRatsBiological AvailabilityMaleRats, Sprague-DawleyReproducibility of ResultsAdministration, OralLinear ModelsChromatography, High Pressure LiquidLimit of DetectionDrug StabilitySensitivity and Specificity

Stichwörter der Autor:innen

LC–MS/MSbioavailabilityhemolysispharmacokineticssaikosaponin A

Substanzen

SaponinsOleanolic Acidsaikosaponin D

Autor:innen und Institutionen

  • College of Medicine, Lishui University, Lishui, China.
  • Xuzhou Medical University, Xuzhou, China.

ORCID-Profile: Zhongwen Sun

Förderung

  • Joint Fund of Zhejiang Provincial Natural Science Foundation of China
  • Lishui University

Zitieren

APA

Sun, Z., Qiu, C., An, Y., Yan, Z., & Li, C. (2025). Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method. Biomedical Chromatography. https://doi.org/10.1002/bmc.70219

Vancouver

Sun Z, Qiu C, An Y, Yan Z, Li C. Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method. Biomedical Chromatography. 2025. doi:10.1002/bmc.70219

BibTeX
@article{Sun2025,
  author = {Sun, Zhongwen and Qiu, Chao and An, Yiqiang and Yan, Zhengyuan and Li, Caifu},
  title = {Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70219}
}
Kostenlos starten →